Benchmarking. Pharmaceutical Expenditure and Cost-Containment (2001)

A brand-new investigation of cost-containment measures for pharmaceuticals in Europe and a critical assessment of their effects - a real necessity for all companies, persons, authorities and other organisations interested in pharma and health care politics

The study provides, in brief, a systematic description of the health care systems in the EU Member States, a comparative investigation of the pharmaceutical systems, a chronological overview on major cost-containment measures for pharmaceuticals, and an in-depth, critical analysis of the effects of these cost-containment strategies.

Key chapters are:

Health care systems: funding, out-patient and in-patient care, reforms
Pharmaceutical systems: registration, reimbursement, pricing, margins, patient co-payments
Cost-containment strategies: presentation and analysis of measures taken in the 1990s
Benchmarking: ranking of key data (pharmaceutical expenditure and consumption, public and private financing) The study is also available in German, called „Benchmarking Arzneimittelausgaben. Strategien zur Kostendämpfung in der Europäischen Union“ (see German version of this text)

The table of content may be downloaded below

 Content

Client: Federal Ministry for Social Security and Generations

Editor: ÖBIG (Austrian Health Institute)

Place of publication: Vienna

Year of publication: 2001

ISBN: 3-85159-025-2

Number of pages: 97 pages, 17 tables, 8 figures

Reimbursement of expenses: € 65,00

Available in German and in English ISBN 3-85159-026-0